Table 3 Frequency of different carcinomatous component pathological types

Serous carcinoma adenocarcinoma

58

44.96%

Endometrioid adenocarcinoma

54

41.86%

Clear cell carcinoma

18

13.95%

Mucinous adenocarcinoma

4

3.10%

Squamous cell carcinoma

3

2.33%

Fusiform cell carcinoma

2

1.55%

Neuron differentiation

2

1.55%

Neuroendocrine differentiation

1

0.78%